Nasal Drug Delivery Market 2018: Merck & Co. Inc., Novartis AG, Johnson & Johnson, Pfizer Inc, AstraZeneca, AptarGroup Inc, GlaxoSmithKline plc., Aegis Therapeutics LLC. Becton, Dickinson and Company, Sisecam Group, Teleflex Medical Europe Ltd

Global Nasal Drug Delivery Market is expected to reach USD 82.28 billion by 2025, from USD 50.09 billion in 2017 growing at a CAGR of 6.4% during the forecast period of 2018 to 2025. The upcoming market report contains data for the historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Global Nasal Drug Delivery Market, By Dosage Form (Nasal Spray, Nasal Drops, Others), Containers (Non-Pressurized Containers, Pressurized Containers), Glass Type (Laminated Glass), Systems (Multi Dose, Bi-Dose, Unit Dose), Therapeutic Application (Allergic & Non-allergic rhinitis, Nose congestion, Others), End Users (Hospitals, Home Care Settings), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)–Industry Trends and Forecast to 2025

• In March 2017, FDA approved the Noctiva (desmopressin acetate) nasal spray for adults suffering from nocturia.

• In January 2017, S. FDA approved Narcan Nasal Spray for the treatment of suspected opioid overdose manifested by respiratory or central nervous system depression.

Free Sample PDF of Report at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-nasal-drug-delivery-market

As per The Royal Australian College of General Practitioners in 2011 and 2012, it was estimated that around 1.9 million Australians have sinusitis problem. As per of centres for disease control and prevention in the U.S. around 26.9 million people were diagnosed with sinusitis. As per WHO, 1 in 12 every individual is having asthma and number is increasing every year.
The nasal airway technology protects the lungs from harmful contacts of drug. Sinusitis is an inflammatory condition that affects nose and paranasal sinuses. As per The Royal Australian College of General Practitioners in 2011 and 2012, it was estimated that around 1.9 million Australians have sinusitis problem.

Major Market Competitors/Players: Global Nasal Drug Delivery Market

Some of the major players operating in the global nasal drug delivery market are:-

• Merck & Co. Inc.,
• Novartis AG,
• Johnson & Johnson,
• Pfizer Inc,
• AstraZeneca,
• AptarGroup Inc,
• GlaxoSmithKline plc.,
• Aegis Therapeutics LLC.
• Becton,
• Dickinson and Company,
• Sisecam Group,
• Teleflex Medical Europe Ltd,
• Procter & Gamble,
• Bespak Europe Ltd,
• Kurve Technology Inc,
• Nemera, AptarGroup Inc.
• Curida AS,
• SMC Ltd,
• Meroven Pharmaceuticals Ltd.,
• Mystic Pharmaceuticals,
• MedPharmand among others.

Competitive Analysis: Global Nasal Drug Delivery Market

The global nasal drug delivery market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of nasal drug delivery market for global, Europe, North America, Asia Pacific and South America.

For More Inquiry Contact us at https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-nasal-drug-delivery-market

Major Market Drivers and Restraints:

• Increasing patient preference for nasal drug delivery as easy administration.
• Increasing emphasis on pediatric and geriatric population
• Better efficacy and better bioavailability.
• Increasing cases of chronic diseases
• Complications of overdose of nasal route of administration.
• Increasing options for other route of administrations.
• Stumbling block of nasal route of administration.

Market Segmentation: Global Nasal Drug Delivery Market

The global nasal drug delivery market is segmented based on :-

• Dosage Form,
• Containers,
• Systems,
• Therapeutic Application,
• End User And
• Geographical Segments.

Based on dosage form, the market is segmented into:-

• Nasal Spray,
• Nasal Drops And Liquids,
• Nasal Gels,
• Nasal Powders And
• Others.

On the containers, the market is classified into:-

• Non-Pressurized Containers,
• Pressurized Containers.

On the basis of therapeutic application, the market is classified into:-

• Allergic &
• Non-Allergic Rhinitis,
• Nose Congestion,
• Vaccination And
• Others.

On the basis of end user, the market is classified into:-

• Hospitals,
• Home Care Settings

Based on geography, the market report covers data points for 28 countries across multiple geographies namely:-

• North America &
• South America,
• Europe,
• Asia-Pacific and,
• Middle East & Africa.

Table of Contents

1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type
10. Geography
10.1. Overview
10.2. North America
10.3. Europe
10.4. Asia-Pacific
10.5. South America
10.6. Middle East & Africa
11. Company Landscape
12. Company Profiles
13. Related Reports

Request for Detailed TOC at https://databridgemarketresearch.com/toc/?dbmr=global-nasal-drug-delivery-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.